How drug-eluting stents illustrate our health system's flawed relationship with technology: comment on "use of drug-eluting stents as a function of predicted benefit"

Comment

. 2012 Aug 13;172(15):1152-3.

doi: 10.1001/archinternmed.2012.2724.

Affiliations

Comment

Peter W Groeneveld. Arch Intern Med. 2012.

. 2012 Aug 13;172(15):1152-3.

doi: 10.1001/archinternmed.2012.2724.

¹ Department of Medicine, University of Pennsylvania School of Medicine, 1229 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104, USA.petergro@upenn.edu

No abstract available

Comment on

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice.
Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Amin AP, et al. Arch Intern Med. 2012 Aug 13;172(15):1145-52. doi: 10.1001/archinternmed.2012.3093. Arch Intern Med. 2012. PMID: 22777536

Costs and clinical outcomes for non-invasive versus invasive diagnostic approaches to patients with suspected in-stent restenosis.
Min JK, Hasegawa JT, Machacz SF, O'Day K. Min JK, et al. Int J Cardiovasc Imaging. 2016 Feb;32(2):309-315. doi: 10.1007/s10554-015-0758-z. Epub 2015 Sep 3. Int J Cardiovasc Imaging. 2016. PMID: 26335370 Free PMC article.